From: Intraocular pressure-lowering effects of Ripasudil: a potential outcome marker for Trabeculotomy
Effective group (n = 14) | Non-effective group (n = 21) | P value | |
---|---|---|---|
Final MD of HFA30–2 (dB) | −8.1 ± 4.8 | −11.8 ± 5.4 | 0.09 |
Glaucoma medications | 1.0 ± 1.3 | 2.0 ± 1.3 | 0.04 |
PGA + β blocker + CAI | 1 | 6 | |
PGA + β blocker + CAI + brimonidine | 1 | 1 | |
PGA + β blocker | 2 | 0 | |
PGA + CAI | 1 | 0 | |
PGA | 1 | 2 | |
β blocker + CAI | 0 | 5 | |
CAI | 0 | 1 |